Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
53
NCT02686281
Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: Apr 30, 2014
NCT02744820
Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics
Start: Apr 30, 2016
Completion: Sep 30, 2017